Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jincao Tablet for Chronic Pelvic Pain after Pelvic Inflammatory Disease
CTR20202153Phase 2Completed
- Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Start
- Oct 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Jincao in chronic prostatitis (CP), Pelviabdominal infection, sponsored by Beijing Konruns Pharmaceutical Co., Ltd.. Started Oct 2020; status: completed.
02
Drugs
Jincao
03
Conditions
chronic prostatitis (CP)Pelviabdominal infection
Beyond the preview
Go deeper on CTR20202153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202153.